Contraindicated (1)pentobarbital will minimize the extent or effect of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with sturdy CYP3A4 inducers can result in decreased serum concentrations and loss of antimalarial efficacy pentobarbital